|
1
|
Zhang C, Bao Z, Zhang W and Jiang T:
Progress on molecular biomarkers and classification of malignant
gliomas. Front Med. 7:150–156. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katakowski M, Buller B, Wang X, Rogers T
and Chopp M: Functional microRNA is transferred between glioma
cells. Cancer Res. 70:8259–8263. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou M, Wang H, Zhou K, Luo X, Pan X, Shi
B, Jiang H, Zhang J, Li K, Wang HM, et al: A novel EGFR isoform
confers increased invasiveness to cancer cells. Cancer Res.
73:7056–7067. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McNamara MG and Mason WP: Antiangiogenic
therapies in glioblastoma multiforme. Expert Rev Anticancer Ther.
12:643–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vaupel P: Hypoxia and aggressive tumor
phenotype: Implications for therapy and prognosis. Oncologist.
13:(Suppl 3). S21–S26. 2008. View Article : Google Scholar
|
|
6
|
Khan UA, Bhavsar A, Asif H, Karabatsou K,
Leggate JR, Sofat A and Kamaly-Asl ID: Treatment by specialist
surgical neurooncologists improves survival times for patients with
malignant glioma. J Neurosurg. 122:297–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hong Y, Shang C, Xue YX and Liu YH:
Silencing of Bmi-1 gene enhances chemotherapy sensitivity in human
glioblastoma cells. Med Sci Monit. 21:1002–1007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Clarke J, Butowski N and Chang S: Recent
advances in therapy for glioblastoma. Arch Neurol. 67:279–283.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Davis FG and McCarthy BJ: Current
epidemiological trends and surveillance issues in brain tumors.
Expert Rev Anticancer Ther. 1:395–401. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Miska EA: How microRNAs control cell
division, differentiation and death. Curr Opin Genet Dev.
15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Magee P, Shi L and Garofalo M: Role of
microRNAs in chemoresistance. Ann Transl Med. 3:3322015.PubMed/NCBI
|
|
15
|
Cellini F, Morganti AG, Genovesi D,
Silvestris N and Valentini V: Role of microRNA in response to
ionizing radiations: Evidences and potential impact on clinical
practice for radiotherapy. Molecules. 19:5379–5401. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan Y, Liang W, Zhao X, Liu L, Qing Y and
Li Y: miR-548b inhibits the proliferation and invasion of malignant
gliomas by targeting metastasis tumor-associated protein-2.
Neuroreport. 27:1266–1273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Xiong M, Hu Y, Sun Y and Ma Q:
MicroRNA-19b inhibits proliferation of gastric cancer cells by
targeting B-cell CLL/lymphoma 3. Oncol Rep. 36:2079–2086.
2016.PubMed/NCBI
|
|
18
|
Liu Y, Uzair-Ur-Rehman, Guo Y, Liang H,
Cheng R, Yang F, Hong Y, Zhao C, Liu M, Yu M, et al: miR-181b
functions as an oncomiR in colorectal cancer by targeting PDCD4.
Protein Cell. 7:722–734. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu MH, Ma CY, Wang XM, Ye CD, Zhang GX,
Chen L and Wang JG: MicroRNA-126 inhibits tumor proliferation and
angiogenesis of hepatocellular carcinoma by down-regulating EGFL7
expression. Oncotarget. 7:66922–66934. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan J, Gumireddy K, Li A and Huang Q:
Regulation of mesenchymal phenotype by MicroRNAs in cancer. Curr
Cancer Drug Targets. 13:930–934. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xiang W, He J, Huang C, Chen L, Tao D, Wu
X, Wang M, Luo G, Xiao X, Zeng F, et al: miR-106b-5p targets tumor
suppressor gene SETD2 to inactive its function in clear cell renal
cell carcinoma. Oncotarget. 6:4066–4079. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Q, Huang Z, Guo W, Ni S, Xiao X, Wang
L, Huang D, Tan C, Xu Q, Zha R, et al: microRNA-202-3p inhibits
cell proliferation by targeting ADP-ribosylation factor-like 5A in
human colorectal carcinoma. Clin Cancer Res. 20:1146–1157. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Josson S, Gururajan M, Hu P, Shao C, Chu
GY, Zhau HE, Liu C, Lao K, Lu CL, Lu YT, et al: miR-409-3p/−5p
promotes tumorigenesis, epithelial-to-mesenchymal transition, and
bone metastasis of human prostate cancer. Clin Cancer Res.
20:4636–4646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yu J, Qiu X, Shen X, Shi W, Wu X, Gu G,
Zhu B and Ju S: miR-202 expression concentration and its clinical
significance in the serum of multiple myeloma patients. Ann Clin
Biochem. 51:543–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Zheng D, Xiong Y, Xue C, Chen G,
Yan B and Ye Q: miR-202 suppresses cell proliferation in human
hepatocellular carcinoma by downregulating LRP6
post-transcriptionally. FEBS Lett. 588:1913–1920. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Emdad L, Sarkar D, Lee SG, Su ZZ, Yoo BK,
Dash R, Yacoub A, Fuller CE, Shah K, Dent P, et al: Astrocyte
elevated gene-1: A novel target for human glioma therapy. Mol
Cancer Ther. 9:79–88. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
He Z, He M, Wang C, Xu B, Tong L, He J,
Sun B, Wei L and Chu M: Prognostic significance of astrocyte
elevated gene-1 in human astrocytomas. Int J Clin Exp Pathol.
7:5038–5044. 2014.PubMed/NCBI
|
|
29
|
Hu B, Emdad L, Bacolod MD, Kegelman TP,
Shen XN, Alzubi MA, Das SK, Sarkar D and Fisher PB: Astrocyte
elevated gene-1 interacts with Akt isoform 2 to control glioma
growth, survival, and pathogenesis. Cancer Res. 74:7321–7332. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee SG, Su ZZ, Emdad L, Sarkar D, Franke
TF and Fisher PB: Astrocyte elevated gene-1 activates cell survival
pathways through PI3K-Akt signaling. Oncogene. 27:1114–1121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hu G, Wei Y and Kang Y: The multifaceted
role of MTDH/AEG-1 in cancer progression. Clin Cancer Res.
15:5615–5620. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gu JJ, Gao GZ and Zhang SM: MiR-218
inhibits the tumorgenesis and proliferation of glioma cells by
targeting Robo1. Cancer Biomark. 16:309–317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stojcheva N, Schechtmann G, Sass S, Roth
P, Florea AM, Stefanski A, Stühler K, Wolter M, Müller NS, Theis
FJ, et al: MicroRNA-138 promotes acquired alkylator resistance in
glioblastoma by targeting the Bcl-2-interacting mediator BIM.
Oncotarget. 7:12937–12950. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu H, Song Z, Liao D, Zhang T, Liu F,
Zheng W, Luo K and Yang L: miR-503 inhibits cell proliferation and
invasion in glioma by targeting L1CAM. Int J Clin Exp Med.
8:18441–18447. 2015.PubMed/NCBI
|
|
35
|
Wang ZY, Xiong J, Zhang SS, Wang JJ, Gong
ZJ and Dai MH: Up-regulation of microRNA-183 promotes cell
proliferation and invasion in glioma by directly targeting NEFL.
Cell Mol Neurobiol. 36:1303–1310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao Y, Li C, Wang M, Su L, Qu Y, Li J, Yu
B, Yan M, Yu Y, Liu B, et al: Decrease of miR-202-3p expression, a
novel tumor suppressor, in gastric cancer. PLoS One. 8:e697562013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma G, Zhang F, Dong X, Wang X and Ren Y:
Low expression of microRNA-202 is associated with the metastasis of
esophageal squamous cell carcinoma. Exp Ther Med. 11:951–956.
2016.PubMed/NCBI
|
|
38
|
Jiang J, Huang J, Wang XR and Quan YH:
MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer
cells through targeting cyclin D1. Eur Rev Med Pharmacol Sci.
20:2278–2284. 2016.PubMed/NCBI
|
|
39
|
Yi Y, Li H, Lv Q, Wu K and Zhang W, Zhang
J, Zhu D, Liu Q and Zhang W: miR-202 inhibits the progression of
human cervical cancer through inhibition of cyclin D1. Oncotarget.
7:72067–72075. 2016.PubMed/NCBI
|
|
40
|
Sun Z, Zhang T, Hong H, Liu Q and Zhang H:
miR-202 suppresses proliferation and induces apoptosis of
osteosarcoma cells by downregulating Gli2. Mol Cell Biochem.
397:277–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Meng X, Chen X, Lu P, Ma W, Yue D, Song L
and Fan Q: MicroRNA-202 inhibits tumor progression by targeting
LAMA1 in esophageal squamous cell carcinoma. Biochem Biophys Res
Commun. 473:821–827. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yu JJ, Shen XJ, Wang XD and Ju SQ: Effect
of miR-202 on the growth of multiple myeloma cells via regulating B
cell-activating factor and the underlying mechanism. Zhonghua Zhong
Liu Za Zhi. 35:886–891. 2013.(In Chinese). PubMed/NCBI
|
|
43
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Zhang N, Song LB, Liao WT, Jiang LL,
Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, et al: Astrocyte elevated
gene-1 is a novel prognostic marker for breast cancer progression
and overall patient survival. Clin Cancer Res. 14:3319–3326. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu X, Wang D, Liu H, Feng Y, Zhu T, Zhang
L, Zhu B and Zhang Y: Knockdown of astrocyte elevated gene-1
(AEG-1) in cervical cancer cells decreases their invasiveness,
epithelial to mesenchymal transition, and chemoresistance. Cell
Cycle. 13:1702–1707. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yoo BK, Emdad L, Su ZZ, Villanueva A,
Chiang DY, Mukhopadhyay ND, Mills AS, Waxman S, Fisher RA, Llovet
JM, et al: Astrocyte elevated gene-1 regulates hepatocellular
carcinoma development and progression. J Clin Invest. 119:465–477.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Emdad L, Lee SG, Su ZZ, Jeon HY, Boukerche
H, Sarkar D and Fisher PB: Astrocyte elevated gene-1 (AEG-1)
functions as an oncogene and regulates angiogenesis. Proc Natl Acad
Sci USA. 106:21300–21305. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yoo BK, Chen D, Su ZZ, Gredler R, Yoo J,
Shah K, Fisher PB and Sarkar D: Molecular mechanism of
chemoresistance by astrocyte elevated gene-1. Cancer Res.
70:3249–3258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lee SG, Su ZZ, Emdad L, Sarkar D and
Fisher PB: Astrocyte elevated gene-1 (AEG-1) is a target
gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase
and c-Myc. Proc Natl Acad Sci USA. 103:17390–17395. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yang Y, Wu J, Guan H, Cai J, Fang L, Li J
and Li M: MiR-136 promotes apoptosis of glioma cells by targeting
AEG-1 and Bcl-2. FEBS Lett. 586:3608–3612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu L, Wu J, Ying Z, Chen B, Han A, Liang
Y, Song L, Yuan J, Li J and Li M: Astrocyte elevated gene-1
upregulates matrix metalloproteinase-9 and induces human glioma
invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
